Clinical Trial Update: Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 study assessing safety and efficacy of desvenlafaxine succinate for vasomotor symptoms in postmenopausal women has completed. Sponsor Wyeth is now a who…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Menopause, Vasomotor System | Phase 3 | Status: COMPLETED